The upgrade from Morgan Stanley is a positive signal for PhenomeX. The new rating of Equal-Weight suggests that the stock is expected to perform in line with the market, which is an improvement from the previous Underweight rating. The $1 price target also provides a clear expectation for the stock's future performance.